| abstract |
The present disclosure provides a phospholipid creatinine 3-kinase (PI3K) inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, wherein n, m, R1, R2, and R3 are as defined herein. Such compounds are useful in the treatment of conditions mediated by one or more PI3K subtypes, such as PI3Kδ. The present disclosure further provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable salt thereof, and the use of such compounds and compositions to treat a condition mediated by one or more PI3K isoforms, such as PI3Kδ. method. |